Your browser version may not work well with NCBI's Web applications. More information here...
1: Clin Experiment Ophthalmol. 2005 Aug;33(4):437-9.Click here to read Links

Visual loss due to central serous chorioretinopathy during corticosteroid treatment for giant cell arteritis.

Bevis T, Ratnakaram R, Smith MF, Bhatti MT.

Department of Ophthalmology, University of Florida College of Medicine, Gainesville, Florida, USA.

Giant cell arteritis (GCA) can be a devastating disease resulting in blindness if not promptly diagnosed and treated. The only proven treatment for GCA is systemic corticosteroids; however, there are many side-effects associated with this therapy including ocular side-effects such as ocular hypertension, cataract formation and central serous chorioretinopathy. To raise physician awareness, a patient with biopsy-proven GCA is reported who lost vision during corticosteroid therapy because of central serous chorioretinopathy.

PMID: 16033370 [PubMed - indexed for MEDLINE]